Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Acute-phase dynamics and prognostic value of growth differentiation factor-15 in ST-elevation myocardial infarction.

Rueda F, Lupón J, García-García C, Cediel G, Aranda Nevado MC, Serra Gregori J, Labata C, Oliveras T, Ferrer M, de Diego O, Serra J, López ER, Bayés-Genís A.

Clin Chem Lab Med. 2019 Feb 1. pii: /j/cclm.ahead-of-print/cclm-2018-1189/cclm-2018-1189.xml. doi: 10.1515/cclm-2018-1189. [Epub ahead of print]

PMID:
30707681
2.

Growth differentiation factor-15 is a predictive biomarker in primary ventricular fibrillation: The RUTI-STEMI-PVF study.

Garcia-Garcia C, Rueda F, Lupon J, Oliveras T, Labata C, Ferrer M, Cediel G, De Diego O, Rodriguez-Leor O, Carrillo X, Bayes-Genis A.

Eur Heart J Acute Cardiovasc Care. 2018 Sep 3:2048872618797599. doi: 10.1177/2048872618797599. [Epub ahead of print]

PMID:
30175597
3.

Primary Ventricular Fibrillation in the Primary Percutaneous Coronary Intervention ST-Segment Elevation Myocardial Infarction Era (from the "Codi IAM" Multicenter Registry).

García-García C, Oliveras T, Rueda F, Pérez-Fernández S, Ferrer M, Serra J, Labata C, Vila J, Carrillo X, Rodríguez-Leor O, Fernández-Nofrerias E, Faixedas MT, Jiménez J, Mauri J, Lupón J, Bayes-Genis A.

Am J Cardiol. 2018 Aug 15;122(4):529-536. doi: 10.1016/j.amjcard.2018.04.054. Epub 2018 Jun 27.

PMID:
29960663
4.

Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction.

Cediel G, Rueda F, Oxvig C, Oliveras T, Labata C, de Diego O, Ferrer M, Aranda-Nevado MC, Serra-Gregori J, Núñez J, García C, Bayes-Genis A.

Cardiovasc Diabetol. 2018 Apr 30;17(1):63. doi: 10.1186/s12933-018-0710-3.

5.

β-Blocker treatment and prognosis in acute coronary syndrome associated with cocaine consumption: The RUTI-Cocaine Study.

Cediel G, Carrillo X, García-García C, Rueda F, Oliveras T, Labata C, Serra J, Ferrer M, de Diego O, Bayés-Genís A.

Int J Cardiol. 2018 Jun 1;260:7-10. doi: 10.1016/j.ijcard.2018.02.013.

PMID:
29622456
6.

Long-term Follow-up of Symptomatic Adult Patients With Noncompaction Cardiomyopathy.

Salazar-Mendiguchía J, González-Costello J, Oliveras T, Gual F, Lupón J, Manito N.

Rev Esp Cardiol (Engl Ed). 2019 Feb;72(2):169-171. doi: 10.1016/j.rec.2017.11.021. Epub 2017 Dec 27. English, Spanish. No abstract available.

PMID:
29289512
7.

Prognostic Value of New-Generation Troponins in ST-Segment-Elevation Myocardial Infarction in the Modern Era: The RUTI-STEMI Study.

Cediel G, Rueda F, García C, Oliveras T, Labata C, Serra J, Núñez J, Bodí V, Ferrer M, Lupón J, Bayes-Genis A.

J Am Heart Assoc. 2017 Dec 23;6(12). pii: e007252. doi: 10.1161/JAHA.117.007252.

8.

Intermediate Care Unit After Cardiac Surgery: Impact on Length of Stay and Outcomes.

Labata C, Oliveras T, Berastegui E, Ruyra X, Romero B, Camara ML, Just MS, Serra J, Rueda F, Ferrer M, García-García C, Bayes-Genis A.

Rev Esp Cardiol (Engl Ed). 2018 Aug;71(8):638-642. doi: 10.1016/j.rec.2017.10.018. Epub 2017 Nov 20. English, Spanish.

PMID:
29158075
9.

Early ST elevation myocardial infarction in non-capable percutaneous coronary intervention centres: in situ fibrinolysis vs. percutaneous coronary intervention transfer.

Carrillo X, Fernandez-Nofrerias E, Rodriguez-Leor O, Oliveras T, Serra J, Mauri J, Curos A, Rueda F, García-García C, Tresserras R, Rosas A, Faixedas MT, Bayes-Genis A; Codi IAM Investigators.

Eur Heart J. 2016 Apr 1;37(13):1034-40. doi: 10.1093/eurheartj/ehv619. Epub 2015 Nov 18.

PMID:
26586783

Supplemental Content

Loading ...
Support Center